Demonstrates a new method for forming C-C bonds in pharmaceuticals using radical cross-coupling, highlighting its synthetic versatility.
The allylic moiety is a prevalent structural motif in pharmaceuticals and bioactive molecules, offering significant synthetic versatility. The conventional Tsuji-Trost reaction relies on transition metal catalysis and preactivated carbon nucleophiles (such as malonates), which often constrain functional group compatibility and reaction diversity. This study introduces a direct radical-radical cross-coupling strategy that capitalizes on polarity matching between π-allylic radicals and amine α-alkyl radicals to facilitate C(sp³)-C(sp³) bond formation. The approach demonstrates remarkable substrate versatility and functional group compatibility, enabling late-stage derivatization of diverse natural products. The reaction also achieves enantioselective control through chiral auxiliaries, such as (-)-menthol, underscoring its synthetic potential.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: